diabetes
FDA U-turn on Avandia
November 26, 2013Sales and Marketing Avandia, CDER, FDA, GSK, diabetes, nissen, type 2
The FDA has delivered a shock verdict that the stringent restrictions on GlaxoSmithKline’s diabetes medicine Avandia should be lifted, despite …
New chief executive for the International Diabetes Federation
November 11, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing diabetes, petra wilson
The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its chief executive. Wilson joins IDF from Cisco, where …
BMS abandons hep C, diabetes and neuroscience
November 11, 2013Sales and Marketing BMS, HIV, diabetes, hep C
Bristol-Myers Squibb is admitting defeat in hepatitis C, diabetes and neuroscience and will abandon research in these areas in a …
Sanofi launches ‘Monster Manor’ diabetes app
October 23, 2013Medical Communications Gamification, Sanofi, diabetes, monster manor
Sanofi has launched a new healthcare app called Monster Manor to help children with type 1 diabetes better manage their …
Sanofi withdraws lixisenatide US application
September 12, 2013Sales and Marketing FDA, Lixisenatide, Sanofi, diabetes, elixa
In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …
GSK banks on bioelectronics with new fund
August 9, 2013Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes
GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …
FDA makes GSK wait
August 6, 2013Sales and Marketing FDA, GSK, albiglutide, diabetes
The FDA is making GlaxoSmithKline wait for a verdict on the manufacturer’s investigational type 2 diabetes treatment albiglutide, extending its …
Boehringer and partners launch digital diabetes study
July 19, 2013Medical Communications Boehringer, Syrum, Twitter, diabetes, digital, type 2
Boehringer Ingelheim has partnered with Healthrageous and United BioSource to establish a new diabetes study to help patients manage their …
Blow for Roche as it halts diabetes drug trial
July 10, 2013Research and Development, Sales and Marketing Roche, aleglitazar, diabetes
Roche has stopped a late-stage trial of its investigational diabetes drug aleglitazar over safety concerns. The move was prompted by …
Diabetes vaccine trial posts positive results
June 28, 2013Research and Development, Sales and Marketing TOL-3021, Vaccine, diabetes
A groundbreaking new study suggests that the body’s immune system can be taught to reverse the effects of type 1 …
Lilly diabetes drug beats rivals
June 25, 2013Sales and Marketing BMS, diabetes, dulaglutide, lilly
New clinical trial results have shown Lilly’s investigational type 2 diabetes drug has beaten its three nearest rivals in reducing …
MedImmune signs diabetes deal
June 18, 2013Research and Development, Sales and Marketing AstraZeneca, MedImmune, diabetes
AstraZeneca R&D subsidiary MedImmune has signed a deal with privately-owned San Francisco-based NGM Biopharmaceuticals to discover novel therapeutics to treat …
Diabetes drug risks fuel transparency debate
June 12, 2013Research and Development, Sales and Marketing BMJ, Channel 4, all trials, diabetes, transaprency
A new investigation by Channel 4’s Dispatches and the British Medical Journal is demanding that all trial data be released …
Pfizer and Merck create major diabetes alliance
April 30, 2013Research and Development, Sales and Marketing Merck, Pfizer, diabetes
Pfizer and Merck have unveiled a major new alliance in diabetes which is likely to raise the stakes in the …
Lilly Phase III diabetes boost
April 17, 2013Research and Development, Sales and Marketing diabetes, dulaglutide, lilly
Eli Lilly and Co’s new type II diabetes candidate dulaglutide – which it intends to file this year – has …
